Healthcare (SH:603313)2018-04-27 16:00Financial Performance - Operating revenue increased by 26.95% to CNY 611,220,106.02 compared to the same period last year[7] - Net profit attributable to shareholders decreased by 93.21% to CNY 4,574,340.20 compared to the same period last year[7] - Basic earnings per share dropped by 92.86% to CNY 0.02 compared to CNY 0.28 in the same period last year[7] - The company reported a significant decline in net profit and cash flow, indicating potential challenges in operational efficiency[7] - The company forecasts a cumulative net profit decrease of 50% to 70% compared to the same period last year, mainly due to rising chemical material costs and foreign exchange losses[15] - Net profit for Q1 2018 was RMB 7,929,845.26, a decrease of 88.2% from RMB 67,071,964.47 in Q1 2017[25] - Net profit for Q1 2018 decreased to CNY 1,581,433.38, down 97.5% from CNY 64,388,667.48 in Q1 2017[28] - The company’s total profit for Q1 2018 was CNY 3,134,138.46, a decrease of 95.9% from CNY 76,300,561.47 in Q1 2017[28] Cash Flow and Liquidity - Net cash flow from operating activities was negative at CNY -9,640,744.83, a decrease of 140.45% compared to the previous year[7] - Cash flow from operating activities showed a net outflow of CNY -9,640,744.83, compared to a net inflow of CNY 23,831,440.56 in the previous year[30] - Cash and cash equivalents at the end of Q1 2018 were CNY 511,702,246.90, down from CNY 979,291,126.42 at the end of Q1 2017[32] - The company’s financial position reflects a significant decrease in cash reserves compared to the previous quarter[34] - The net increase in cash and cash equivalents was -$114.10 million, contrasting with an increase of $374.95 million in the prior period[34] Assets and Liabilities - Total assets decreased by 2.06% to CNY 2,261,087,349.75 compared to the end of the previous year[7] - The company's total assets decreased to RMB 2,094,812,133.30 from RMB 2,117,480,912.54 at the beginning of the year[22] - The total liabilities decreased to ¥711,745,664.38 from ¥763,818,867.25[19] - Total liabilities decreased to RMB 524,962,411.30 from RMB 549,212,623.92 at the beginning of the year[22] - The company's inventory decreased to ¥310,119,427.91 from ¥325,631,472.86[17] - Inventory decreased to RMB 175,051,086.31 from RMB 184,678,758.06 at the beginning of the year[21] Shareholder Information - The total number of shareholders was 22,669 at the end of the reporting period[11] - The largest shareholder, Ni Zhanggen, holds 63.71% of the shares, with 141,641,980 shares pledged[11] Operating Costs and Expenses - Operating costs rose by 41.58% to ¥459,017,810.71, mainly attributed to the increase in chemical material costs[14] - The company reported a significant increase in sales expenses to RMB 71,328,133.16 from RMB 45,669,800.98 in the previous year[25] - Total operating expenses increased to CNY 758,556,948.51, up from CNY 492,788,614.46 in the same period last year[30] - Financial expenses surged by 2299.67% to ¥23,308,330.90, primarily due to increased foreign exchange losses[14] - The company reported a significant increase in financial expenses, amounting to CNY 23,261,365.59, compared to a financial income of CNY -803,819.59 in the previous year[27] Investments - Long-term equity investments increased by 46.82% to ¥40,343,182.95, due to increased investments in joint ventures[13] - The company invested $60.38 million in fixed assets and intangible assets during the quarter[34]